VANCOUVER, Sept. 17 /CNW/ - Protox Therapeutics Inc. (TSX-V:PRX) today
announced that Dr. Fahar Merchant, President and CEO of Protox, will be
presenting at the Fourth AdMeTech Foundation Conference in Washington, D.C.
The conference is a multi-disciplinary forum where leaders of philanthropy,
advocacy, government, industry, academia, media and communications will
discuss innovative ideas and partnerships to expedite fundamental advances in
cancer imaging, with prostate cancer as a model. The goal of the AdMeTech
Foundation is to shift prostate cancer care from the current era of blind
diagnosis and treatment to the future of image-guided, minimally invasive and
precisely targeted interventions. The presentation by Dr. Merchant entitled
Minimally Invasive Image-Guided Delivery of Targeted Toxins for the Treatment
of Cancer will take place at the L'enfant Plaza Hotel at 1:30pm EST on
September 17, 2007.
